EWA
TNYA icon

EP Wealth Advisors’s Tenaya Therapeutics TNYA Stock Holding History

EP Wealth Advisors’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.58K Buy
+10,250
New +$7.78K ﹤0.01% 1712
2024
Q4 		– Sell
-11,224
Closed -$21.7K – 1323
2024
Q3 		$21.7K Buy
+11,224
New +$31.7K ﹤0.01% 1172

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EP Wealth Advisors's TNYA Position: Q2 2026 in Review

EP Wealth Advisors opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 10,250 shares worth $7.58K. The stake represents ﹤0.01% of the portfolio and ranks #1712 among its holdings. This is a return to the name: EP Wealth Advisors previously reported a position in TNYA as recently as Q3 2024.

EP Wealth Advisors first reported a position in TNYA in Q3 2024 and has held it in 2 quarters since. The position peaked at $21.7K in Q3 2024. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • EP Wealth Advisors held 10,250 shares of Tenaya Therapeutics worth $7.58K as of Q2 2026.
  • Tenaya Therapeutics was a new EP Wealth Advisors position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #1712 holding.
  • EP Wealth Advisors first reported a position in Tenaya Therapeutics in Q3 2024 and has held it in 2 quarters since.
  • EP Wealth Advisors's Tenaya Therapeutics position peaked at $21.7K in Q3 2024.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.